| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| nivolumab and pembrolizumab side effects | 2 | 0.5 | 4612 | 57 | 40 |
| nivolumab | 1.6 | 0.7 | 7550 | 32 | 9 |
| and | 1.36 | 0.3 | 5681 | 55 | 3 |
| pembrolizumab | 0.07 | 0.6 | 4236 | 40 | 13 |
| side | 0.09 | 0.2 | 1843 | 21 | 4 |
| effects | 0.35 | 0.2 | 2941 | 53 | 7 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| nivolumab and pembrolizumab side effects | 0.37 | 1 | 5899 | 91 |
| side effects of nivolumab | 1.32 | 0.6 | 9839 | 94 |
| nivolumab side effects management | 1.43 | 0.7 | 7125 | 41 |
| side effects of nivolumab and ipilimumab | 1.51 | 0.6 | 7842 | 80 |
| nivolumab neurologic side effects | 1.26 | 0.7 | 1923 | 49 |
| pembrolizumab neurological side effects | 1.74 | 0.8 | 5153 | 56 |
| side effects for pembrolizumab | 0.42 | 0.5 | 7948 | 9 |
| nivolumab and pembrolizumab combination | 0.95 | 0.9 | 4416 | 56 |
| nivolumab potential side effect | 0.06 | 0.6 | 8215 | 84 |
| common side effects of pembrolizumab | 0.63 | 0.5 | 9620 | 28 |
| adverse effects of nivolumab | 0.61 | 0.6 | 8170 | 3 |
| pembrolizumab severe side effects | 1.46 | 1 | 4130 | 81 |
| nivolumab side effects for adults | 0.51 | 0.5 | 3981 | 9 |
| pembrolizumab side effects uk | 0.24 | 0.5 | 9306 | 95 |
| nivolumab side effects lung | 1.03 | 0.8 | 8051 | 25 |
| pembrolizumab side effects lung | 0.85 | 0.9 | 8658 | 91 |
| nivolumab side effects skin | 1.8 | 0.1 | 3575 | 79 |
| adverse effects of pembrolizumab | 0.94 | 0.8 | 9379 | 10 |
| pembrolizumab compared to nivolumab | 0.2 | 0.1 | 2075 | 100 |
| pembrolizumab immune related adverse events | 1.52 | 0.9 | 154 | 16 |
